Phosphodiesterase (PDE)4 inhibitors: anti-inflammatory drugs of the future?

Trends in Pharmacological Sciences
M M TeixeiraP G Hellewell

Abstract

Phosphodiesterase type 4 (PDE4) plays a major role in modulating the activity of virtually all cells involved in the inflammatory process. Inhibitors of this enzyme family display impressive anti-inflammatory and disease-modifying effects in a variety of experimental models. In this review, Mauro Teixeira, Robert Gristwood, Nicola Cooper and Paul Hellewell examine the capacity of PDE4 inhibitors to exert anti-inflammatory actions in vivo and discuss the potential of this class of drugs to take their place as novel therapeutic agents for a variety of inflammatory diseases.

References

May 25, 1992·Nucleic Acids Research·P VrekenH A Raué
Jun 19, 1991·International Journal of Cancer. Journal International Du Cancer·W T van der GraafN H Mulder
Aug 1, 1990·The American Review of Respiratory Disease·R DjukanovićS T Holgate
Jan 8, 1981·The New England Journal of Medicine·E G NassifW Huntley
Oct 1, 1995·Trends in Pharmacological Sciences·J R Parratt, L Szekeres
Apr 11, 1995·Proceedings of the National Academy of Sciences of the United States of America·C P GenainS L Hauser
Jun 1, 1995·American Journal of Respiratory and Critical Care Medicine·V LagenteI Moodley
Feb 1, 1995·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·W ElwoodK F Chung
Mar 30, 1995·The New England Journal of Medicine·P J Barnes
Sep 1, 1994·Cardiovascular Research·M L Entman, C W Smith
May 1, 1994·British Journal of Pharmacology·M M TeixeiraP G Hellewell
May 1, 1994·American Journal of Respiratory and Critical Care Medicine·C R TurnerJ W Watson
Jun 1, 1993·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·J C KipsR A Pauwels
Apr 1, 1993·The Journal of Clinical Investigation·N SuttorpC Schudt
Feb 1, 1996·Circulation Research·R RabinoviciL F Neville
Dec 1, 1995·Trends in Pharmacological Sciences·M M TeixeiraP G Hellewell
Aug 1, 1996·Trends in Pharmacological Sciences·T MüllerJ R Fozard
Aug 1, 1996·British Journal of Pharmacology·M M TeixeiraP G Hellewell

❮ Previous
Next ❯

Citations

Dec 20, 2003·Bioorganic & Medicinal Chemistry Letters·Hiroshi OchiaiMasaaki Toda
Dec 20, 2003·Bioorganic & Medicinal Chemistry Letters·Hiroshi OchiaiMasaaki Toda
Feb 26, 2004·Bioorganic & Medicinal Chemistry Letters·Hiroshi OchiaiMasaaki Toda
Feb 12, 2004·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Junghee HanByungbae Kim
Jun 1, 2005·Pharmacology & Therapeutics·María Jesús SanzEsteban J Morcillo
Jun 14, 2000·European Journal of Pharmacology·R PonsE J Morcillo
Apr 6, 2001·European Journal of Pharmacology·G A BritoR A Ribeiro
Dec 22, 1999·Trends in Pharmacological Sciences·C WardA G Rossi
Nov 27, 1999·International Journal of Immunopharmacology·K D LaemontD J Schrier
Nov 11, 1998·General Pharmacology·M C Weston, P T Peachell
Jan 5, 1999·Bioorganic & Medicinal Chemistry Letters·S C BeasleyJ B Warneck
Jan 5, 1999·Bioorganic & Medicinal Chemistry Letters·J G MontanaJ B Warneck
Jan 5, 1999·Bioorganic & Medicinal Chemistry Letters·J G MontanaJ B Warneck
Sep 16, 1998·Current Opinion in Chemical Biology·M J Perry, G A Higgs
Apr 18, 2002·British Journal of Pharmacology·María-Jesús SanzEsteban J Morcillo
Apr 18, 2006·Journal of Cardiothoracic and Vascular Anesthesia·Nicola A HornRolf Rossaint
Mar 21, 1998·Proceedings of the National Academy of Sciences of the United States of America·S Tertyshnikova, A Fein
Sep 11, 2009·Respirology : Official Journal of the Asian Pacific Society of Respirology·Jin Bing PanGuo Jun Zhang
Jun 18, 2005·American Journal of Respiratory and Critical Care Medicine·Piero A MartoranaGiuseppe Lungarella
Oct 14, 2003·American Journal of Respiratory and Critical Care Medicine·Huib A M Kerstjens, Wim Timens
Sep 25, 2009·Multiple Sclerosis : Clinical and Laboratory Research·Bibiana BielekovaRoland Martin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.